-
Je něco špatně v tomto záznamu ?
Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens
M. Cervinkova, P. Kucerova, J. Cizkova,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy, práce podpořená grantem
- MeSH
- lidé MeSH
- melanom imunologie MeSH
- melanomové antigeny imunologie MeSH
- nádory kůže imunologie MeSH
- spontánní regrese nádoru imunologie MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
Malignant melanoma (MM) is the most aggressive and uneasily treatable form of skin cancer. Up to 90% of deaths because of skin tumours are estimated to be caused by this malignancy. Spontaneous regression is described as a partial or complete disappearance of cancer. It can be defined if the clinical and histological diagnosis of malignancy is verified and any therapeutic intervention potentially inducing mechanisms leading to regression has not been applied. Regression occurs more frequently in melanoma than in other types of tumours; it is reported to be six times higher than in other malignancies. Up to 50% of primary MM is reported to undergo spontaneous regression. However, spontaneous regression of the metastatic form of tumour is a rare phenomenon observed in only 0.23% of cases. The most frequently mentioned factors leading to spontaneous regression of MM are operative trauma, infection, vaccination (BCG and rabies vaccines) and immunological factors. Other well-documented circumstances associated with regression of metastatic MM include blood transfusion and various endocrine factors.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016550
- 003
- CZ-PrNML
- 005
- 20180517110106.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/CAD.0000000000000526 $2 doi
- 035 __
- $a (PubMed)28609309
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Cervinkova, Monika $u aLaboratory of Tumour Biology, Institute of Animal Physiology and Genetics, Czech Academy of Sciences, v.v.i., Libechov bDepartment of Surgery, 1st Medical Faculty, Charles University and Hospital Na Bulovce cDepartment of Veterinary Sciences, Faculty of Agrobiology, Food and Natural Resources, Czech University of Life Sciences, Prague, Czech Republic.
- 245 10
- $a Spontaneous regression of malignant melanoma - is it based on the interplay between host immune system and melanoma antigens / $c M. Cervinkova, P. Kucerova, J. Cizkova,
- 520 9_
- $a Malignant melanoma (MM) is the most aggressive and uneasily treatable form of skin cancer. Up to 90% of deaths because of skin tumours are estimated to be caused by this malignancy. Spontaneous regression is described as a partial or complete disappearance of cancer. It can be defined if the clinical and histological diagnosis of malignancy is verified and any therapeutic intervention potentially inducing mechanisms leading to regression has not been applied. Regression occurs more frequently in melanoma than in other types of tumours; it is reported to be six times higher than in other malignancies. Up to 50% of primary MM is reported to undergo spontaneous regression. However, spontaneous regression of the metastatic form of tumour is a rare phenomenon observed in only 0.23% of cases. The most frequently mentioned factors leading to spontaneous regression of MM are operative trauma, infection, vaccination (BCG and rabies vaccines) and immunological factors. Other well-documented circumstances associated with regression of metastatic MM include blood transfusion and various endocrine factors.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a melanom $x imunologie $7 D008545
- 650 _2
- $a melanomové antigeny $x imunologie $7 D058950
- 650 _2
- $a spontánní regrese nádoru $x imunologie $7 D009365
- 650 _2
- $a nádory kůže $x imunologie $7 D012878
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kucerova, Petra
- 700 1_
- $a Cizkova, Jana
- 773 0_
- $w MED00179775 $t Anti-cancer drugs $x 1473-5741 $g Roč. 28, č. 8 (2017), s. 819-830
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28609309 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180517110242 $b ABA008
- 999 __
- $a ok $b bmc $g 1300174 $s 1013390
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 28 $c 8 $d 819-830 $i 1473-5741 $m Anticancer Drugs $n Anticancer Drugs $x MED00179775
- LZP __
- $a Pubmed-20180515